Form 4: Bankwell Financial Group Director Demos Acquires Shares in Open Market and Discloses Vesting of Restricted Stock

Sentiment:

SEC Form 4 Filing


Bankwell Financial Group director Darryl Demos acquired 2,290 shares of common stock and disclosed the vesting schedule of previously granted restricted stock.

Summary

  • Darryl Demos, a director at Bankwell Financial Group, purchased 765 shares of common stock at $32.62 per share and 1,525 shares at $32.60 per share on December 13, 2024.
  • Following these transactions, Mr. Demos directly owns 8,156 shares of Bankwell Financial Group common stock.
  • The filing also details the vesting schedule of restricted stock granted to Mr. Demos in 2022 and 2023.
  • A total of 2,500 shares were granted on December 29, 2023, with 833 vesting immediately, 833 vesting on February 7, 2024, and 834 scheduled to vest on February 7, 2025.
  • Another 1,600 shares were granted on December 29, 2023, vesting in three equal annual installments starting February 7, 2025.
  • Additionally, 1,600 shares were granted on December 30, 2022, vesting in four equal annual installments, with the first vesting on January 2, 2024.

Sentiment

Score: 7

Explanation: The document reflects routine insider trading activity and vesting schedules, which are generally neutral to positive. The open market purchases by the director suggest confidence in the company.

Positives

  • The director's open market purchases of 2,290 shares at $32.62 and $32.60 per share could be seen as a positive signal of confidence in the company's future.
  • The vesting of restricted stock aligns the director's interests with those of shareholders.

Future Outlook

The document outlines the future vesting schedule of restricted stock grants, indicating future share ownership changes for the director.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in the financial industry and is required by the SEC to ensure transparency.

Comparison to Industry Standards

  • SEC Form 4 filings are standard practice for publicly traded companies, and this filing is consistent with those requirements.
  • The vesting schedules for restricted stock are typical for executive compensation packages in the financial industry.
  • The open market purchases are not unusual and are often seen as a positive sign of management's confidence in the company.

Stakeholder Impact

  • The director's stock purchases may positively influence shareholder sentiment.
  • The vesting of restricted stock aligns the director's interests with those of shareholders.

Next Steps

  • The next vesting dates for restricted stock are February 7, 2025, and subsequent annual anniversaries.

Key Dates

DateDescription
2022-12-30Grant date of 1,600 restricted stock shares under the 2012 plan.
2023-12-29Grant date of 2,500 and 1,600 restricted stock shares under the 2022 plan.
2023-12-29833 shares of restricted stock vested immediately.
2024-01-02First vesting date of 400 shares from the 2022-12-30 grant.
2024-02-07833 shares of restricted stock vested.
2024-12-13Darryl Demos purchased 2,290 shares of common stock.
2024-12-17Date of filing of the SEC Form 4.
2025-02-07834 shares of restricted stock are scheduled to vest.
2025-02-07First vesting date of 25% of the 1,600 shares granted on 2023-12-29.

Keywords

Bankwell Financial Group, Darryl Demos, stock purchase, restricted stock, insider trading, vesting, director, BWFG

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.